ReviewBiomolecules2026

Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions.

Ahmed Ismail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.